The Maryland Transportation Authority announced the approval of three contracts in the Key Bridge rebuild Wednesday.

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

We are proud to continue our city's rich history in world-leading engineering, innovation and creativity. We carry out ground-breaking research. We work closely with our governmental and industrial ...

Vertex Resource Group Ltd. provides environmental ... and well sub-surface engineering services; advisory services, including estimating, project controls, and facility engineering; land and ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Vertex offers up to $70,000 in fertility services assistance for patients undergoing Casgevy treatment. HHS claims Vertex’s program incentivizes patients to choose its gene therapy over competitors.

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

In December, the FDA approved Vertex’s vanzacaftor ... Bioengineering for the Circular Bio-Economy within the College of Engineering and Architecture Applications are sought for an Assistant ...